ZYC-13070-94271
3 vaccinations
1 coded response
25 check-ins
1 free-text entry
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 765 / TX
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to workAdult check-in
- 2021-01-08
-
2021-01-14
Health check-in — day 7, dose 1Feeling: Poor · Fever · Chills, Headache, Abdominal pain · Be unable to workAdult check-in
- 2021-01-14
- 2021-01-21
- 2021-01-28
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-28
- 2021-03-05
- 2021-03-12
- 2021-05-01
- 2021-07-30
-
2021-12-15
Dose 3 — Pfizer-BioNTech
- 2022-01-29
- 2022-01-29
-
2022-03-16
Survey response — 3 months, dose 3MedDRA: COVID-19, Heart rate increased, Parosmia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: High heart rate, my smell is off since I had COVID in January.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-16
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-17
- 2022-06-17
- 2022-12-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-08 | priority 2/3 | |
| 2021-01-14 | priority 2/3 | |
| 2022-03-16 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Symptoms: High heart rate, my smell is off since I had COVID in January.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release